Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues

被引:154
作者
Jiménez-Huete, A
Lievens, PMJ
Vidal, R
Piccardo, P
Ghetti, B
Tagliavini, F
Frangione, B
Prelli, F
机构
[1] NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA
[2] Ist Nazl Neurol Carlo Besta, Milan, Italy
[3] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA
关键词
D O I
10.1016/S0002-9440(10)65744-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We have investigated the proteolytic cleavage of the cellular (PrPC) and pathological (PrPSc) isoforms of the human prion protein (PrP) in normal and prion-affected brains and in tonsils and platelets from neurologically intact individuals. The various PrP species were resolved after deglycosylation according to their electrophoretic mobility, immunoreactivity, Sarkosyl solubility, and, as a novel approach, resistance to endogenous proteases, First, our data show that PrPC proteolysis in brain originates amino-truncated peptides of 21 to 22 and 18 (C1) kd that are similar in different regions and are not modified by the PrP codon 129 genotype, a polymorphism that affects the expression of prion disorders. Second, this proteolytic cleavage of PrPC in brain is blocked by inhibitors of metalloproteases. Third, differences in PrPC proteolysis, and probably in Asn glycosylation and glycosylphosphatidylinositol anchor composition, exist between neural and non-neural tissues. Fourth, protease-resistant PrPSc cores in sporadic Creutzfeldt-Jakob disease (CJD) and Gerstmann-Straussler-Scheinker F198S disease brains all have an intact C1 cleavage site (Met111-His112), which precludes disruption of a domain associated with toxicity and fibrillogenesis. Fifth, the profile of endogenous proteolytic PrPSc peptides is characteristic of each disorder studied, thus permitting the molecular classification of these prion diseases without the use of proteinase K and even a recognition of PrPSc heterogeneity within type 2 CJD patients having different codon 129 genotype and neuropathological phenotype, This does not exclude the role of additional factors in phenotypic expression; in particular, differences in glycosylation that may be especially relevant in the new variant CJD. Proteolytic processing of PrP may play an important role in the neurotropism and phenotypic expression of prion diseases, but it does not appear to participate in disease susceptibility.
引用
收藏
页码:1561 / 1572
页数:12
相关论文
共 61 条
[1]   NEARLY UBIQUITOUS TISSUE DISTRIBUTION OF THE SCRAPIE AGENT PRECURSOR PROTEIN [J].
BENDHEIM, PE ;
BROWN, HR ;
RUDELLI, RD ;
SCALA, LJ ;
GOLLER, NL ;
WEN, GY ;
KASCSAK, RJ ;
CASHMAN, NR ;
BOLTON, DC .
NEUROLOGY, 1992, 42 (01) :149-156
[2]   IDENTIFICATION OF A PROTEIN THAT PURIFIES WITH THE SCRAPIE PRION [J].
BOLTON, DC ;
MCKINLEY, MP ;
PRUSINER, SB .
SCIENCE, 1982, 218 (4579) :1309-1311
[3]   MOLECULAR LOCATION OF A SPECIES-SPECIFIC EPITOPE ON THE HAMSTER SCRAPIE AGENT PROTEIN [J].
BOLTON, DC ;
SELIGMAN, SJ ;
BABLANIAN, G ;
WINDSOR, D ;
SCALA, LJ ;
KIM, KS ;
CHEN, CMJ ;
KASCSAK, RJ ;
BENDHEIM, PE .
JOURNAL OF VIROLOGY, 1991, 65 (07) :3667-3675
[4]   SCRAPIE AND CELLULAR PRION PROTEINS DIFFER IN THEIR KINETICS OF SYNTHESIS AND TOPOLOGY IN CULTURED-CELLS [J].
BORCHELT, DR ;
SCOTT, M ;
TARABOULOS, A ;
STAHL, N ;
PRUSINER, SB .
JOURNAL OF CELL BIOLOGY, 1990, 110 (03) :743-752
[5]   NEUROPATHOLOGICAL DIAGNOSTIC-CRITERIA FOR CREUTZFELDT-JAKOB-DISEASE (CJD) AND OTHER HUMAN SPONGIFORM ENCEPHALOPATHIES (PRION DISEASES) [J].
BUDKA, H ;
AGUZZI, A ;
BROWN, P ;
BRUCHER, JM ;
BUGIANI, O ;
GULLOTTA, F ;
HALTIA, M ;
HAUW, JJ ;
IRONSIDE, JW ;
JELLINGER, K ;
KRETZSCHMAR, HA ;
LANTOS, PL ;
MASULLO, C ;
SCHLOTE, W ;
TATEISHI, J ;
WELLER, RO .
BRAIN PATHOLOGY, 1995, 5 (04) :459-466
[6]   PRION ISOLATE SPECIFIED ALLOTYPIC INTERACTIONS BETWEEN THE CELLULAR AND SCRAPIE PRION PROTEINS IN CONGENIC AND TRANSGENIC MICE [J].
CARLSON, GA ;
EBELING, C ;
YANG, SL ;
TELLING, G ;
TORCHIA, M ;
GROTH, D ;
WESTAWAY, D ;
DEARMOND, SJ ;
PRUSINER, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5690-5694
[7]   CELLULAR ISOFORM OF THE SCRAPIE AGENT PROTEIN PARTICIPATES IN LYMPHOCYTE-ACTIVATION [J].
CASHMAN, NR ;
LOERTSCHER, R ;
NALBANTOGLU, J ;
SHAW, I ;
KASCSAK, RJ ;
BOLTON, DC ;
BENDHEIM, PE .
CELL, 1990, 61 (01) :185-192
[8]   NON-ALZHEIMERS DISEASE AMYLOIDOSES OF THE NERVOUS-SYSTEM [J].
CASTANO, EM ;
FRANGIONE, B .
CURRENT OPINION IN NEUROLOGY, 1995, 8 (04) :279-285
[9]   TRUNCATED FORMS OF THE HUMAN PRION PROTEIN IN NORMAL BRAIN AND IN PRION DISEASES [J].
CHEN, SG ;
TEPLOW, DB ;
PARCHI, P ;
TELLER, JK ;
GAMBETTI, P ;
AUTILIOGAMBETTI, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19173-19180
[10]   Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD [J].
Collinge, J ;
Sidle, KCL ;
Meads, J ;
Ironside, J ;
Hill, AF .
NATURE, 1996, 383 (6602) :685-690